Green Cross (South Korean company)
Founded | October 5, 1967 |
---|---|
Headquarters | Yongin, South Korea |
Key people | Eun Chul Huh (President) |
Services | Manufacturing and sales of biotheapeutics. |
Website | http://gcbiopharma.com/ http://www.globalgreencross.com/eng/index.do |
GC Biopharma [Green Cross Corporation] (KRX: 006280) is a biopharmaceutical company headquartered in Yongin, South Korea.
GC Biopharma specializes in the development and commercialization of vaccines, protein therapies, and therapeutic antibodies for use in the fields of oncology and infectious disease.
GC Biopharma was established as "Sudo Microorganism Medical Supplies Co." in 1967, and changed the name to "Green Cross" in 1971. The company is engaged in research, development, manufacturing and sales of biotherapeutics, including plasma proteins, recombinant antibodies, and vaccines. Green Cross developed "Hepavax B", the world's third hepatitis B vaccine, in 1983, the world's first vaccine “Hantavax” against epidemic hemorrhagic fever in 1988, the world's second varicella vaccine in 1995, "Greengene", the world's 4th recombinant antihemophilic drug, and the world's second treatment of Hunter syndrome “Hunterase” in 2012.
As part of GC Biopharma's global strategies, there are three operations based in the overseas as of 2016.
- GC China was established in Anhui Province, China and, has produced plasma derivative products. GC China has established a pharmaceutical wholesaler in 2012.
- GCAM was established in December 2009 to secure plasma supply and enter into the US market. The company, currently runs a total of 8 plasma centers in the US, and collects 400,000 liters of plasma a year that meets FDA standards for facilities and quality and supplies it to Green Cross.
- GCBT is a Montreal-based biopharmaceutical company that was established in 2014 and is Green Cross’ business expansion into the North American and European markets. Building a state-of-the-art manufacturing facility for plasma proteins, GCBT will become the only intravenous immunoglobulin and albumin producer in Canada. It will also serve as a North American hub for the distribution of a variety of therapeutic products from the Green Cross family.[1]
- MOGAM Institute [2] was established in 1984 by Dr. Young-sup Huh who was the first CEO and chairman of GC Biopharma (Green Cross Corporation). In 1970, he dedicated his life to create a sustainable biopharmaceutical industry in South Korea for the benefit of Koreans. Since then, his work led to the development of the world's third Hepatitis B vaccine. In 1984, Dr. Huh founded the MOGAM Institute using all of the profit generated from Green Cross Pharmaceuticals. Since its inception, MOGAM has made significant contributions to Korea's biomedical industry by successfully producing vaccines, diagnostic kits, and important recombinant proteins.
Products
- Plasma proteins
- Recombinant antibody and proteins
- Vaccines
- Prescription drugs
- Consumer healthcare
References
External links
- Official website
- Business data for Green Cross:
- Bloomberg
- Reuters
- Yahoo!
- v
- t
- e
- Amorepacific
- Amorepacific Group
- Asiana Airlines
- BGF Retail
- BNK Financial
- Celltrion
- Cheil Worldwide
- Chong Kun Dang
- CJ
- CJ CheilJedang
- CJ Logistics
- Cosmax
- Cosmo Chemical
- Coway
- CS Wind
- Daesang
- Daewoo E&C
- Daewoong
- Daewoong Pharmaceutical
- DB HiTek
- DB Insurance
- Dentium
- DGB Financial
- DL
- DL E&C
- Dongsuh
- Dongwon Systems
- Doosan
- Doosan Bobcat
- Doosan Enerbility
- Doosan Fuel Cell
- DoubleU Games
- Ecopro Materials
- Emart
- F&F
- Fila
- Foosung
- Grand Korea Leisure
- Green Cross
- Green Cross Holdings
- GS
- GS E&C
- GS Retail
- Hana Financial
- Hana Tour
- Hanall Biopharma
- Hanil Cement
- Hanjin KAL
- Hankook & Company
- Hankook
- Hanmi Pharm
- Hanmi Science
- Hanon Systems
- Hansae
- Hansol Chemical
- Hanssem
- Hanwha
- Hanwha Aerospace
- Hanwha Life
- Hanwha Ocean
- Hanwha Solutions
- Hanwha Systems
- HD Hyundai
- HD Hyundai Electric
- HD Hyundai Heavy
- HD Hyundai Infracore
- HD KSOE
- HiteJinro
- HL Mando
- HMM
- Hotel Shilla
- Hybe
- Hyosung
- Hyosung Advanced Materials
- Hyosung TNC
- Hyundai Department Store
- Hyundai Elevator
- Hyundai E&C
- Hyundai Glovis
- Hyundai Marine & Fire
- Hyundai Mipo Dockyard
- Hyundai Mobis
- Hyundai Motor
- Hyundai Rotem
- Hyundai Steel
- Hyundai WIA
- Iljin Hysolus
- Industrial Bank of Korea
- IS Dongseo
- JB Financial Group
- Kakao
- KakaoBank
- KakaoPay
- Kangwon Land
- KB Financial
- KCC
- KEPCO
- KEPCO E&C
- KEPCO KPS
- KG Mobility
- KG Steel
- Kia
- Kiwoom Securities
- Kolmar Korea
- Kolon
- Korea Aerospace
- Korea Gas
- Korea Investment
- Korea Petrochemical
- Korea Zinc
- Korean Air
- Krafton
- KT
- KT&G
- Kumho Petrochemical
- Kumho Tire
- Kumyang
- LG
- LG Chem
- LG Display
- LG Electronics
- LG Energy Solution
- LG H&H
- LG Innotek
- LG Uplus
- LIG Nex1
- Lotte
- Lotte Chemical
- Lotte Chilsung
- Lotte Fine Chemical
- Lotte Energy Materials
- Lotte Shopping
- Lotte Tour Development
- Lotte Wellfood
- LS
- LS Electric
- LX International
- Meritz Financial
- Mirae Asset Securities
- Myoungshin
- Naver
- NCSoft
- Netmarble
- NH Investment & Securities
- Nongshim
- OCI
- Orion
- Orion Holdings
- Ottogi
- Pan Ocean
- PI Advanced Materials
- Poongsan
- POSCO
- POSCO Future M
- POSCO International
- S-1 Corporation
- Sama Aluminium
- Samsung Biologics
- Samsung C&T
- Samsung Card
- Samsung Electro-Mechanics
- Samsung Electronics
- Samsung Engineering
- Samsung Fire & Marine
- Samsung Heavy
- Samsung Life
- Samsung SDI
- Samsung SDS
- Samsung Securities
- Samyang Foods
- SD Biosensor
- Seah Besteel
- Sebang
- Shinhan Financial
- Shinpoong
- Shinsegae
- Shinsegae International
- SK
- SK Biopharm
- SK Bioscience
- SK Chemical
- SK Hynix
- SK IE Technology
- SK Innovation
- SK Networks
- SK Square
- SK Telecom
- SKC
- SL
- S-Oil
- Ssangyong C&E
- Taihan
- TCC Steel
- TKG Huchems
- Woori Financial
- Youlchon Chemical
- Young Poong
- Youngone
- Youngone Holdings
- Yuhan